Edap Tms (EDAP) Set to Announce Quarterly Earnings on Thursday

Edap Tms (NASDAQ:EDAP) is set to announce its earnings results before the market opens on Thursday, May 16th. Analysts expect the company to announce earnings of ($0.10) per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

Edap Tms (NASDAQ:EDAP) last announced its quarterly earnings results on Wednesday, March 27th. The medical equipment provider reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.13). The company had revenue of $21.27 million during the quarter, compared to analysts’ expectations of $21.30 million. Edap Tms had a negative net margin of 35.03% and a negative return on equity of 34.33%. On average, analysts expect Edap Tms to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Edap Tms Stock Performance

Shares of NASDAQ EDAP opened at $7.10 on Thursday. Edap Tms has a 1-year low of $3.60 and a 1-year high of $12.09. The business has a fifty day moving average price of $7.42 and a 200 day moving average price of $6.30. The stock has a market capitalization of $263.44 million, a P/E ratio of -11.27 and a beta of 0.65. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.84 and a quick ratio of 2.30.

Analyst Ratings Changes

A number of brokerages have recently issued reports on EDAP. HC Wainwright lifted their price objective on shares of Edap Tms from $16.00 to $19.00 and gave the stock a “buy” rating in a research report on Monday, April 1st. StockNews.com downgraded Edap Tms from a “hold” rating to a “sell” rating in a research report on Friday, May 3rd.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.